Analog Devices (NASDAQ:ADI) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $285.00 price target on the stock. This represents a 16.4% upside from the current price of $244.81. |
Automatic Data Processing (NASDAQ:ADP) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $340.00 price target on the stock. This represents a 10.3% upside from the current price of $308.24. |
Altimmune (NASDAQ:ALT) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $1.00 price target on the stock. This represents a 77.1% downside from the current price of $4.38. |
Applied Materials (NASDAQ:AMAT) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $225.00 price target on the stock. This represents a 13.5% upside from the current price of $198.16. |
Advanced Micro Devices (NASDAQ:AMD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $140.00 price target on the stock. This represents a 2.4% downside from the current price of $143.41. |
Amkor Technology (NASDAQ:AMKR) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $20.00 price target on the stock. This represents a 9.2% downside from the current price of $22.03. |
Amylyx Pharmaceuticals (NASDAQ:AMLX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $10.00 price target on the stock. This represents a 36.9% upside from the current price of $7.30. |
ANI Pharmaceuticals (NASDAQ:ANIP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $84.00 price target on the stock. This represents a 28.4% upside from the current price of $65.43. |
ARM (NASDAQ:ARM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $160.00 price target on the stock. This represents a 8.5% upside from the current price of $147.44. |
ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $33.00 price target on the stock. This represents a 54.5% upside from the current price of $21.37. |
Broadcom (NASDAQ:AVGO) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $315.00 price target on the stock. This represents a 15.0% upside from the current price of $274.03. |
Burke & Herbert Financial Services (NASDAQ:BHRB) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating and a $70.00 price target on the stock. This represents a 7.6% upside from the current price of $65.09. |
Cadence Design Systems (NASDAQ:CDNS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $380.00 price target on the stock. This represents a 18.5% upside from the current price of $320.74. |
CG Oncology (NASDAQ:CGON) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $40.00 price target on the stock. This represents a 49.7% upside from the current price of $26.72. |
Cinemark (NYSE:CNK) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $36.00 price target on the stock. This represents a 22.4% upside from the current price of $29.42. |
Crinetics Pharmaceuticals (NASDAQ:CRNX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $36.00 price target on the stock. This represents a 15.0% upside from the current price of $31.29. |
Equifax (NYSE:EFX) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $280.00 price target on the stock. This represents a 5.4% upside from the current price of $265.77. |
Estee Lauder Companies (NYSE:EL) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $110.00 price target on the stock. This represents a 20.8% upside from the current price of $91.06. |
Entegris (NASDAQ:ENTG) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $85.00 price target on the stock. This represents a 3.4% downside from the current price of $88.02. |
Equinix (NASDAQ:EQIX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $933.00 price target on the stock. This represents a 23.2% upside from the current price of $757.58. |
Geron (NASDAQ:GERN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $1.00 price target on the stock. This represents a 28.3% downside from the current price of $1.40. |
GlobalFoundries (NASDAQ:GFS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $40.00 price target on the stock. This represents a 3.2% downside from the current price of $41.33. |
Halozyme Therapeutics (NASDAQ:HALO) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $55.00 price target on the stock. This represents a 3.7% downside from the current price of $57.11. |
Harmony Biosciences (NASDAQ:HRMY) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $33.00 price target on the stock. This represents a 5.3% downside from the current price of $34.86. |
IDEAYA Biosciences (NASDAQ:IDYA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $25.00 price target on the stock. This represents a 11.7% upside from the current price of $22.39. |
Immunovant (NASDAQ:IMVT) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $18.00 price target on the stock. This represents a 5.3% upside from the current price of $17.09. |
KLA (NASDAQ:KLAC) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $980.00 price target on the stock. This represents a 5.8% upside from the current price of $926.00. |
Lam Research (NASDAQ:LRCX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $115.00 price target on the stock. This represents a 14.1% upside from the current price of $100.79. |
Microchip Technology (NASDAQ:MCHP) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $88.00 price target on the stock. This represents a 14.7% upside from the current price of $76.73. |
MKS (NASDAQ:MKSI) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $90.00 price target on the stock. This represents a 15.8% downside from the current price of $106.89. |
Marvell Technology (NASDAQ:MRVL) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $75.00 price target on the stock. This represents a 3.9% upside from the current price of $72.18. |
Micron Technology (NASDAQ:MU) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $150.00 price target on the stock. This represents a 22.0% upside from the current price of $122.99. |
Micron Technology (NASDAQ:MU) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $130.00 price target on the stock. This represents a 5.7% upside from the current price of $122.99. |
Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $182.00 price target on the stock. This represents a 35.8% upside from the current price of $134.04. |
Nano Nuclear Energy (NASDAQ:NNE) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $51.00 price target on the stock. This represents a 46.5% upside from the current price of $34.80. |
NAPCO Security Technologies (NASDAQ:NSSC) is now covered by analysts at Mizuho. They set an "outperform" rating and a $39.00 price target on the stock. This represents a 24.6% upside from the current price of $31.30. |
NVIDIA (NASDAQ:NVDA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $185.00 price target on the stock. This represents a 13.7% upside from the current price of $162.67. |
NXP Semiconductors (NASDAQ:NXPI) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $276.00 price target on the stock. This represents a 18.3% upside from the current price of $233.35. |
ON Semiconductor (NASDAQ:ON) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $60.00 price target on the stock. This represents a 1.4% upside from the current price of $59.20. |
Paychex (NASDAQ:PAYX) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $160.00 price target on the stock. This represents a 9.9% upside from the current price of $145.57. |
Performant Healthcare (NASDAQ:PHLT) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $8.00 price target on the stock. This represents a 82.2% upside from the current price of $4.39. |
Performant Healthcare (NASDAQ:PHLT) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $8.00 price target on the stock. This represents a 82.2% upside from the current price of $4.39. |
Qorvo (NASDAQ:QRVO) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $90.00 price target on the stock. This represents a 0.6% downside from the current price of $90.55. |
Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $55.00 price target on the stock. This represents a 82.1% upside from the current price of $30.21. |
Roivant Sciences (NASDAQ:ROIV) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $19.00 price target on the stock. This represents a 68.8% upside from the current price of $11.26. |
Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $97.00 price target on the stock. This represents a 9.7% upside from the current price of $88.42. |
Sandisk (NASDAQ:SNDK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $55.00 price target on the stock. This represents a 19.0% upside from the current price of $46.20. |
Syndax Pharmaceuticals (NASDAQ:SNDX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $18.00 price target on the stock. This represents a 93.1% upside from the current price of $9.32. |
Synopsys (NASDAQ:SNPS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $620.00 price target on the stock. This represents a 12.6% upside from the current price of $550.83. |
Seagate Technology (NASDAQ:STX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $170.00 price target on the stock. This represents a 18.7% upside from the current price of $143.21. |
Skyworks Solutions (NASDAQ:SWKS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $70.00 price target on the stock. This represents a 9.9% downside from the current price of $77.69. |
Teradyne (NASDAQ:TER) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $80.00 price target on the stock. This represents a 17.1% downside from the current price of $96.51. |
TG Therapeutics (NASDAQ:TGTX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $37.00 price target on the stock. This represents a 1.9% downside from the current price of $37.73. |
Transcat (NASDAQ:TRNS) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $105.00 price target on the stock. This represents a 19.0% upside from the current price of $88.21. |
Texas Instruments (NASDAQ:TXN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $255.00 price target on the stock. This represents a 16.3% upside from the current price of $219.24. |
Western Digital (NASDAQ:WDC) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $130.00 price target on the stock. This represents a 99.0% upside from the current price of $65.34. |
0 Response to "🌎 Advanced Micro Devices Upgraded, NVIDIA Initiated, Lam Research Initiated and more..."
Post a Comment